Mandate

Vinge advises Cellink in conjunction with the acquisition of Scienion Ag

Vinge has advised Cellink AB, listed on Nasdaq Stockholm, in connection with the acquisition of all shares in Scienion Ag. Scienion is a life science company which focuses on precision dimensioning technology.

The Scienion group conducts operations in Germany, the United States, France and England. The purchase price for the shares, on a cash‑free and debt‑free basis, amounts to EUR 80 million, of which EUR 40 million is paid in cash and the remaining EUR 40 million is paid in newly issued Cellink shares. Closing is expected to take place at the end of August whereupon Cellink’s board of directors will adopt a resolution concerning the issue in kind in accordance with the authorization resolved at the company’s general meeting. Cellink intends to perform a new issue of shares in order to finance the cash element of the purchase price.

Vinge’s team has consisted of, among others, Anders StridMartin E Svanberg (M&A), Edin Agic (Capital Markets) as well as Anna Palmérus (Competition Law). Hengeler Mueller advised Cellink in Germany.

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025